The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- 2025 Timebooks Are On the Way
- SMART-TD Announces 2025 Regional Training Seminars
- Strike Avoided: SMART-TD Local 1594 Reaches Tentative Agreement with SEPTA. A Victory for Transit Workers’ Safety and Dignity
- Virginia and D.C. legislative boards merge
- Help find the LA shooter responsible for attempted murder of SMART-TD transit member
- A tribute to a family railroad legacy
- Michigan Senate Committee Passes SB 100 for Two-Person Minimum Crew Law
- Urgent Appeal for SMART-TD Brother Nii Nunoo and Family
- Amtrak Thinks No AC Is No Problem! They Are Dead Wrong
- Alabama & Gulf Coast Members Ratify New Agreement